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The effects of actomyosin disruptors on the mechanical integrity
of the avian crystalline lens
Gah-Jone Won,1 Douglas S. Fudge,2 Vivian Choh1
School of Optometry and Vision Science, University of Waterloo, Ontario, Canada; 2Department of Integrative Biology,
University of Guelph, Guelph, Canada
1

Purpose: Actin and myosin within the crystalline lens maintain the structural integrity of lens fiber cells and form a
hexagonal lattice cradling the posterior surface of the lens. The actomyosin network was pharmacologically disrupted
to examine the effects on lenticular biomechanics and optical quality.
Methods: One lens of 7-day-old White Leghorn chickens was treated with 10 µM of a disruptor and the other with 0.01%
dimethyl sulfoxide (vehicle). Actin, myosin, and myosin light chain kinase (MLCK) disruptors were used. The stiffness
and the optical quality of the control and treated lenses were measured. Western blotting and confocal imaging were used
to confirm that treatment led to a disruption of the actomyosin network. The times for the lenses to recover stiffness to
match the control values were also measured.
Results: Disruptor-treated lenses were significantly less stiff than their controls (p≤0.0274 for all disruptors). The disruptors led to changes in the relative protein amounts as well as the distributions of proteins within the lattice. However, the
disruptors did not affect the clarity of the lenses (p≥0.4696 for all disruptors), nor did they affect spherical aberration
(p≥0.2245). The effects of all three disruptors were reversible, with lenses recovering from treatment with actin, myosin,
and MLCK disruptors after 4 h, 1 h, and 8 min, respectively.
Conclusions: Cytoskeletal protein disruptors led to a decreased stiffness of the lens, and the effects were reversible. Optical quality was mostly unaffected, but the long-term consequences remain unclear. Our results raise the possibility that
the mechanical properties of the avian lens may be actively regulated in vivo via adjustments to the actomyosin lattice.

In most cells, the f-actin function relies on its ability
to interact with myosin II, a non-muscle and smooth
muscle motor protein, to form actomyosin assemblies [10].
In smooth- and non-muscle systems, the contraction of
actin and myosin is triggered by myosin light chain kinase
(MLCK), an upregulator of ATPase activity and a catalyst
for actin-myosin cross-linking [11-13]. The ATP is used by
myosin heads to move along actin filaments and results in the
contractile movement of myofilaments. In squirrels, rabbits,
and humans, f-actin is arranged in polygonal arrays at the
anterior faces of crystalline lenses and is associated with
myosin within the epithelium [14]. Similarly, at the posterior
surface of the avian crystalline lens, f-actin, non-muscle
myosin, and N-cadherin are arranged in a hexagonal lattice
resembling a “two-dimensional muscle” [15]. The actomyosin
complex at the anterior epithelium has been speculated to
facilitate accommodation by allowing the epithelial cells to
change shape or by permitting the lens as a whole to change
into a more spherical shape [16]. Furthermore, the proteins
collectively at the basal membrane complex (BMC) of the
posterior lens surface have been shown to mediate fiber cell
migration across, and anchor fiber cells to, the lens capsule
[15]. In addition, the presence of highly regular actomyosin
lattices in the lens raises the possibility that these networks
are involved in setting the passive biomechanical response

The process of accommodation allows for the eye to focus
on nearby objects. The mechanism by which this occurs in
vertebrates involves either a translation of the lens or a change
in the lens curvature to increase the optical power of the eye
[1]. Humans and birds are similar in that both species use the
latter method to accommodate [1,2]. However, the changes in
the human lens occur via the relaxation of zonules attached
to the ciliary muscle [1,3], whereas the ciliary muscle in the
avian eye directly articulates with the equator of the lens [2],
resulting in a squeezing of the lens in the equatorial plane.
The lens maintains its integrity and transparency due to
the organization of its cells, which are epithelial in origin
[4-6]. Similar to other epithelial cells in the body, lens epithelial cells contain cytoskeletal filaments, the smallest of which
are known as microfilaments and are found throughout the
lens [7]. Microfilaments are composed largely of filamentous
f-actin and are responsible for an array of essential biologic
functions, including facilitating changes in cell shape, fortifying cell–cell and cell–extracellular matrix interactions, and
compartmentalizing plasma membranes [8,9].

Correspondence to: Vivian Choh, 200 University Ave West,
Waterloo, ON, N2L 3G1 Canada, Phone: +1 519 888-4567 x35005;
FAX: +1 519 725-0784; email: vchoh@uwaterloo.ca
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of the avian lens to external forces, such as those exerted
by the ciliary muscle. Indeed, previous research using
knockout mice has shown that in the murine lens, beaded filaments, which are intermediate filaments unique to the lens,
contribute significantly to lens stiffness [17]. Furthermore,
the fact that the actomyosin network has the potential to be
contractile raises two even more intriguing possibilities: that
lens stiffness could be actively tuned by adjusting the amount
of tension in the network and that the shape of the lens itself
could be similarly adjusted [15,16,18-20]. The demonstration
that the MLCK inhibitor, ML-7, has significant effects on
the focal length, and therefore almost certainly the shape
of avian lenses seems to support this idea [21]. The purpose
of this study was to test the hypothesis that lenticular actomyosin networks affect the biomechanics and optics of the
whole avian lens by pharmacologically disrupting them and
measuring the effects on lens stiffness and optical clarity.

and high affinity for several class II myosins and acts by
reducing the actin affinity of the myosin heads [25]. Finally,
1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride (ML-7) selectively disrupts MLCK
activity by preventing myosin II light-chain phosphorylation
[26].
Lens treatments: For each bird, one eye was treated for 15
min with either 10 μM latrunculin (n = 18) in 0.01% (v/v)
dimethyl sulfoxide (DMSO) in TS, 10 μM blebbistatin (n =
16) in 0.01% (v/v) DMSO in TS, or 10 μM ML-7 (n = 14) in
0.01% (v/v) DMSO in TS. The lenses from the opposite eyes
were subjected to a vehicle (0.01% (v/v) DMSO in TS; 15
min). Assignment to the treatment group alternated between
left and right eyes. All lenses were briefly rinsed in TS before
biomechanical testing, western blot analysis, immunocytochemical processing, or assessment of optical quality.
Lens compressions: The mechanical properties of the lenses
were measured using a universal testing machine (Instron,
Norwood, MA). Each lens was placed anterior side down on
a pedestal located in the compression chamber containing
chilled TS (Figure 1). Lenses were then compressed by 0.75
mm using an aluminum compression element connected to
a 10-N load cell, and measurements of the resultant force
exerted by the lenses were collected. For experiments examining whether the effects on the biomechanics were reversible,
a 5-N sensitive load cell was used and compressions were
performed in disruptor- and vehicle-free TS. This was done
immediately after the 15 min disruptor/vehicle treatment at
the following time points: 1 min, 2 min, 4 min, 8 min, 16 min,
32 min, 1 h, 2 h, 4 h, 8 h, 16 h, and 32 h after treatment. The
force compression data for each lens were collected using
Bluehill software (ver. 9, Instron).

METHODS
Animals: White leghorn (Gallus gallus domesticus) hatchling chicks were obtained from the Maple Leaf hatchery
in New Hamburg, Ontario and were fed ad libitum. They
were housed in stainless steel brooders with a heat source
and kept on a 14 h:10 h light-dark cycle. Chicks were raised
in accordance with the Guidelines of the Canadian Council
on Animal Care and with the ARVO Statement for the Use
of Animals in Ophthalmic and Vision Research. As the
focus of this study was to test the fundamental question of
whether disrupting cytoskeletal proteins could have an effect
on lenticular biomechanics, chicks with robust amounts of
accommodation (about a week old) were used instead of older
birds, which will be considered for a future study once the
functions of disruptors have been well established. Week-old
chicks also show highly monotonic spherical aberrations
(SAs) [22], thereby providing a model against which optical
changes could be assessed.

Analysis of stiffness: Force data were adjusted to account
for the buoyancy exerted by the surrounding solution on the
compression element, as it displaced more or less test solution
during compression and relaxation of the lens. The resulting

Lens dissections: Chicks that were 6–8 days old were sacrificed by decapitation and their eyes were enucleated. Eyes
were placed in chilled oxygenated Tyrode’s solution (TS:
134 mM NaCl, 3 mM KCl, 20.5 mM NaHCO3, 1 mM MgCl2,
3 mM CaCl 2) before removal of the posterior globe and
vitreous humor. The exposed lens was then separated from
the surrounding ciliary body and extracted from the anterior
segment, taking care to minimize damage to the lens capsule.
Disruptors: Latrunculin A (LAT-A) is a drug that rapidly,
reversibly, and specifically disrupts actin cytoskeleton by
preventing polymerization [23,24]. As well, 1-phenyl-1,2,3,4tetrahydro-4-hydroxypyrrolo[2.3-b]-7-methylquinolin-4-one
(blebbistatin) is a reversible inhibitor with a specificity

Figure 1. Image of a lens in the compression chamber. The lens
(arrow) is submerged in TS, sitting anterior side up on a pedestal
and compressed from above by an aluminum compression element
connected to a load cell.
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force-compression curves that were generated for each lens
were then best fit to a three-parameter exponential curve with
the equation y = y0 + aebx. As the b-coefficient of the exponential equation is a unitless constant that describes the relationship of how rapidly the force increases as the compression
distance increases, it was used to assess the relative stiffness
between lenses [27,28] with larger numerical values for the
b-coefficient representing steeper curves, and thus stiffer
lenses. B-coefficients from each curve were extracted, and
means and standard deviations were calculated from these
data. Dimensionless b-coefficient values for whole lenses
should not be confused with the Young’s Modulus, which
is known to vary in different parts of the lens [29] and was
not measured in this study. It should be noted there were no
significant differences in the sizes of the control and treated
lenses; thus, differences in the b-coefficients likely correspond to differences in the Young’s Modulus of at least part
of the lens, although our data cannot tell us which part.
Western blot: A western blot analysis was performed to
confirm that disruptors had the expected effects on the lenses.
Disruptor and vehicle treatments were identical to those for
the compression trials. Lenses were dissected and separated
into 1) BMC samples, which include posterior capsule and
sheared ends of lens fiber cells still attached to the membrane,
and 2) decapsulated lens fiber samples, composed of cortical
and nuclear fibers. Each sample was separately ground using
mini pestles and lysed with radioimmunoprecipitation assay
buffer (RIPA; R0278, Sigma-Aldrich Co., Oakville, ON,
Canada) containing a general use protease inhibitor cocktail
(P2714, Sigma-Aldrich Co.). The total protein of the lens
tissue samples was quantified using the BioRad DC protein
assay (500–0111; BioRad Laboratories, Inc., Mississauga,
ON, Canada). Samples were prepared with a Laemmli sample
buffer, run on 10% precast gels (456–1033, BioRad Laboratories, Inc.) in the BioRad Mini-Protean System (165–8000,
BioRad Laboratories, Inc.), transferred to a polyvinyldene
f luoride (PVDF; 162–0175, BioRad Laboratories, Inc.)
membrane, and visualized with antibodies specific to the
protein being blotted. Mono- and polymeric actin levels in
the lens capsule were quantified using a globular (g-) actin/
filamentous (f-) actin in vivo assay biochemistry kit (BKO37,
Cytoskeleton, Inc., Denver, CO). In brief, lens samples were
homogenized, and a detergent-based lysis buffer that stabilizes and maintains the globular and filamentous forms of
cellular actin was added. The lysate containing each sample
was then centrifuged (21,100 × g, Thermo Scientific Sorvall
Legend Micro) [21], with the resulting supernatant and pellet
containing g-actin and f-actin, respectively. Actin levels
in both the supernatant and pellet were then quantified by
a western blot analysis for three replicates, each consisting
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of a minimum of four lens tissue extracts. ML-7 inhibits
MLCK, which phosphorylates myosin; therefore, antibodies
against phosphorylated myosin (M6068, Sigma-Aldrich) were
used for ML-7-treated samples. An anti-beta actin antibody
(ab8224, Abcam Inc., Toronto, ON, Canada) was used as
a loading control. Secondary antibodies conjugated with
horseradish peroxidase were detected by enhanced chemiluminescence using Amersham ECL prime (RPN2236, GE
Healthcare, Mississauga, ON, Canada). Western blots were
visualized using a Storm 860 scanner (GE Healthcare) and
assessed using the ImageQuant software (GE Healthcare).
Optical quality: The optical quality of the lenses was assessed
using a ScanTox© scanning laser monitor. In brief, lenses
were placed anterior side down in a rectangular glass chamber
in TS and 5% fetal bovine serum, with the latter used to
visualize the helium-neon laser beams passing through the
lens at various eccentricities from the optical axis. Refracted
beams were captured and recorded with a camera, and back
vertex focal lengths were calculated using software associated with the scanner. Beams passing through the sutures
were omitted, as they produce highly inaccurate back vertex
focal lengths. The optical quality of the lenses was assessed
based on changes in scatter and spherical aberration (SA).
For calculations of SA, data were first converted to dioptric
values (vergences) using a thin lens approximation in water;
the refractive index of water (nW = 1.33) was divided by the
back vertex focal lengths (in meters). The vergences were
then fitted using a third-order polynomial line of regression to
determine the back vertex distance at the optical axis (Figure
2). The amounts of SA were determined for a 1.5 mm pupil
size by averaging the SA calculations for the positive (0 to
0.75 mm) and negative (0 to −0.75 mm) eccentricities. As bird
lenses typically show a high negative SA [22,30-32], scatter
was quantified as the mean deviation of the various focal
lengths from the best fitting third-order polynomial line of
regression. Higher deviations indicated higher degrees of
scatter.
Confocal microscopy: Blebbistatin- and latrunculin-treated
lenses and the controls for these lenses were fixed with 2%
(v/v) paraformaldehyde in TS. Lenses were permeabilized in
toto using 0.05% v/v Triton X-100 in PBS before the addition of a mouse anti-myosin-light-chain antibody (M4401,
Sigma-Aldrich, 1:100 dilution in PBS, 2 h at 37 °C) followed
by a rabbit anti-mouse secondary antibody conjugated to
Texas Red (1:500 in PBS, overnight at RT). Following a
3×5 min wash, lenses were counterstained with phalloidin
FITC (P5282, Sigma-Aldrich, 1:400 dilution in PBS, 15 min,
RT). Lenses were mounted in toto posterior pole up onto
slides using 5% (w/v) agar solution in water with 0.05 mg/
100
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Figure 2. Effects of disruptors
on lenticular optics. Line graph
showing the focal length (mm)
at various eccentricities (mm) of
a typical avian crystalline lens.
Graphs were fitted with third-order
polynomial equations to calculate
the amount of scatter and SA.

ml phenylenediamene (P6001, Sigma-Aldrich; in 50% (v/v)
glycerol in water). A coverslip coated with ProLong Gold
(P36934, Life Technologies) was then placed on top of the
posterior pole of the lens and adhered to the slide with the
agar. The protein distribution of lenses was visualized using
a Zeiss LSM 510 confocal microscope and images were
captured and processed using the Zen 2011 software (Zeiss).
Nearest neighbor analysis: Protein distributions were quantified using a nearest neighbor analysis, which assesses the
closeness of points of interest (POIs) on an image and assigns
a value between 0 and 2.15, where a score of 0 represents
clustered POIs, a score of 1 represents a random distribution
of POIs, and a score of 2.15 is a highly regular distribution
of POIs. For latrunculin-treated lenses (n = 3), the POIs used
were the vertices of actin hexagons, while for blebbistatintreated lenses (n = 3), the POIs used were the center of myosin
globules. POIs were targeted and selected using NIH Image
or Scion Image software. Nearest neighbor values (R n) were
calculated using the equation

Rn = D(Obs ) / 0.5

a
n'

Where DObs) is the mean observed nearest neighbor
distance, a is the area, and n is the total number of POIs.
Statistical analysis: The effects of the disruptors on the
stiffness and optical quality of the lenses were analyzed
using a mixed-model analysis of variance (ANOVA), with
disruptor versus vehicle as the repeated measure and the type
of disruptor used as a factor. For the longitudinal (reversibility) study, a two-way repeated-measured ANOVA was
used with the disruptor versus vehicle as one measure and
time as the other. Tukey or Bonferroni-corrected post-hoc
multiple comparison tests were performed where applicable.
Comparisons of the optical quality of the lenses, as well as
of nearest neighbor values were assessed using paired t tests.

For all statistical tests, results were considered significant at
p≤0.05.
RESULTS
Force-compression curves were generated for each lens
(Figure 3). A linear regression of the data to a three-parameter exponential curve (y = y + aebx) yielded mean r2 values
(± SEM) of 0.9861±0.0217 (range: 0.8787 and 0.9999). For
most pairs of lenses, treatment with disruptors was associated
with a decrease in the stiffness of the lens, as indicated by
the shallower force-compression curves (Figure 3, solid grey
lines and filled symbols). Specifically, for 15 of 18 pairs of
eyes in the latrunculin group, treated lenses exhibited relatively lower stiffness values for the latrunculin-treated lenses
compared to the vehicle-control, while three pairs showed
the opposite trend, with stiffness in the latrunculin-treated
lenses being relatively higher than in those exposed to the
vehicle. The mean stiffness values reflected the general
trend, with latrunculin-treated lenses being significantly
lower (± SEM) at 2.64±1.28 compared to the vehicle-treated
lenses at 4.15±1.15 (p = 0.0011; Figure 4A). Similarly, 14 of
16 pairs of lenses showed relatively lower stiffness values
for the blebbistatin-treated lenses compared to the vehicletreated counterparts, with two pairs showing the opposite
trend. Again, the mean stiffness values (± SEM) were lower
for the blebbistatin-treated lenses (3.25±0.23) than for those
exposed to the vehicle (4.47±0.57; p = 0.0274; Figure 4B).
Finally, for 12 of 14 pairs of lenses, the stiffness values of the
ML-7 treated lenses were relatively lower compared to the
vehicle-treated lenses, while the values for two pairs of lenses
were relatively higher. The mean stiffness value for the ML-7treated lenses was, again, lower than for the counterpart eyes
(2.90±1.19 versus 4.49±1.23, respectively; p = 0.0027; Figure
4C). A mixed model analysis revealed neither significant
differences in the stiffness levels between the disruptors (p =
0.2379) nor an interaction effect (p = 0.7483).
101
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A western blot analysis indicated that latrunculin and
ML-7 treatments were effective in disrupting actin levels
and myosin phosphorylation, respectively, at both the BMC
and the lens fibers. Actin levels in latrunculin-treated lenses
were quantified using a g-actin/f-actin in vivo assay kit,
which revealed a large decrease in f-actin both at the BMC
and in the lens fiber cells as a result of lens tissue treatment.
In BMC samples treated with latrunculin, the mean intensity
(± SEM) of f-actin was 12.0±1.2, while the mean intensity of
g-actin was 19.3±1.9, representing 38.4±0.5% and 61.6±0.5%
of the total actin amount, respectively, indicating substantial
depolymerization of f-actin as a result of latrunculin treatment (Figure 5A, top panel). In comparison, control samples
showed a ratio of approximately 1:1, with mean intensities of
f- and g-actin at 14.2±1.4 and 13.7±1.4, representing 51.0±0.5%
and 49.0±0.5% of the total actin amount, respectively. In the
lens fiber samples treated with latrunculin, the mean intensity
(± SEM) of f-actin was 10.0±1.6, while the mean intensity of
g-actin was 18.3±1.9, representing 35.4±0.6% and 64.7±0.7%
of the total actin amount, respectively (Figure 5A; bottom

© 2015 Molecular Vision

panel). In comparison, control samples again showed a ratio
of approximately 1:1, with mean intensities of f- and g-actin at
13.4±1.3 and 13.3±1.2, representing 50.1±0.5% and 49.9±0.5%
of the total actin amount, respectively. The relative intensities of phospho-myosin were lower in both BMC (by 49.8%;
treated versus control: 18.6±3.0 versus 55.5±1.9, respectively)
and lens fiber cell samples (by 35.7%; treated versus control:
9.1±2.2 versus 19.2±3.1, respectively) when treated with ML-7
(Figures 5B, left and right panels, respectively), indicating an
ML-7-dependent inhibition of myosin phosphorylation.
Confocal images indicated that latrunculin led to the
rearrangement and thinning of the actin cables at the basal
membrane (Figure 6). Actin in the latrunculin-treated lenses
appeared different from the vehicle-treated lenses, which
showed the typical punctate staining of the highly regular
hexagonal vertices. Additionally, myosin bundles localized
at the center of the actin formations appeared more variable
in size and neighboring distance. A nearest neighbor analysis
indicated a significant increase in the disorder of the myosin
associated with the actin lattice (R nm for treated lenses:

Figure 3. Force-compression curves
of all lenses. Mean force ± SEM of
(A) latrunculin-, (B) blebbistatin-,
and (C) ML-7-treated lenses (filled
symbols) and their controls (empty
symbols), as a function of compression. Force-compression curves of
individual disruptor-treated (solid
gray lines) and vehicle-treated
(dashed gray lines) lenses are also
included.
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Figure 4. Effects of disruptors on
lenticular stiffness. Mean stiffness
values ± SEM of disruptor- and
vehicle-treated lenses for (A) 10
µM latrunculin (n = 18), (B) 10 µM
blebbistatin (n = 16), and (C) 10 µM
ML-7 (n = 14). Asterisks denote
significant differences (all groups
p≤0.0274).

Figure 5. Effects of disruptors on
protein concentrations in the lens.
(A) Western blots of f- and g-actin
in BMC and lens fiber cell samples
treated with latrunculin. Numbers
in parentheses represent the mean
percentage optical density (±SEM)
relative to the total amount of actin.
(B) Western blots of phosphomyosin in BMC and lens fiber
cell samples treated with ML-7.
Numbers in parentheses represent
the mean optical densities (±SEM).
β-actin was used as the loading
control.
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Figure 6. Effects of disruptors on
actin and myosin distributions
in the lens. Confocal images of
posterior lens capsules showing
the distribution of actin (green) and
myosin (red) in a (A) latrunculintreated lens and (B) its vehicletreated counterpart, as well as a (C)
blebbistatin-treated lens and (D) its vehicle-treated counterpart. Scale bar = 5 µm for all images. R n values for actin (R na, green) and myosin
(R nm, red) distributions are included.

1.751±0.023 versus R nm for control lenses: 2.056±0.054; p =
0.0025). The actin distribution in latrunculin-treated lenses
had an R na (± SEM) of 1.826±0.047, while its vehicle-treated
counterpart had an R na of 2.091±0.054, indicating a small
increase in f-actin disorder (Figures 6A, B), although these
changes were not significant (p = 0.0593).
Both actin and myosin organizations were adversely
affected by blebbistatin. The myosin distributions in lenses
treated with blebbistatin were even less ordered than those
observed in latrunculin-treated lenses, and treated lenses
showed an even lower R nm of 1.576±0.081, while their vehicletreated counterparts had an R nm of 2.054±0.031 (p = 0.0183,
Figures 6C, D). The actin distribution was also affected;
blebbistatin-treated lenses lost the regular repeating arrays of
punctate staining, and the R na of 1.158±0.022 in these lenses
was significantly different from that in the control lenses, at
an R na of 2.001±0.005 (p = 0.0183), indicating a large increase
in disorder.

Despite the rearrangement of the cytoskeletal proteins
at the BMC, the optical quality of disruptor-treated lenses,
assessed using two criteria, scatter and SA (Table 1), were
unaffected. The disruptor-treated lenses showed neither a
difference in the amounts of scatter compared to their respective controls (p≥0.4696; Table 1) nor did any disruptor treatments result in differences in the amount of SA (p≥0.2245;
Table 1). In the longitudinal (reversibility) compression trials,
it was found that lenses treated with latrunculin took the
longest to recover, showing significant differences in stiffness up until the 4-h mark, (mean stiffness ± SEM at 4 h:
control lenses, 6.17±0.43 versus treated lenses, 4.98±0.56; p
= 0.0730; Figure 7A). Lenses treated with blebbistatin were
found to have a recovery time of 1 h (mean stiffness at 1
h: control lenses, 5.37±0.19 versus treated lenses, 5.27±0.51;
p = 1.000; Figure 7B). Lenses treated with ML-7 had the
quickest recovery time at 8 min (mean stiffness at 8 min:
control lenses, 6.02±0.36 versus treated lenses, 5.17±0.40; p
= 1.000; Figure 7C).

Table 1. Mean spherical aberration (D) ± SEM and mean scatter (mm) ± SEM for latrunculin-, blebbistatin-, and ML-7-treated lenses and their controls.
Disruptor
Latrunculin
Blebbistatin
ML-7

Spherical aberration (D)
Treated

Control

−11.80±0.50

−11.57±0.48

(−9.13 to −13.94)

(−9.51 to −14.30)

−11.62±0.31

−11.59±0.26

(−9.84 to −13.13)

(−10.13 to −12.95)

−11.94±0.69

−12.44±0.78

(−7.95 to −15.06)

(−7.54 to −16.84)

Scatter (Mean deviation; mm)
P value
0.6093
0.9212
0.2245

Ranges are in parentheses.
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Treated

Control

1.15±0.03

1.15±0.04

(1.00 to 1.36)

(0.93 to 1.36)

1.19±0.07

1.14±0.02

(1.01 to 1.83)

(1.06 to 1.21)

1.15±0.03

1.13±0.05

(0.91 to 1.25)

(0.81 to 1.32)

P value
0.9858
0.4696
0.7526
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DISCUSSION
The compression trials showed that treatment with actomyosin
disruptors results in significant changes in the distributions
of actin and myosin and significant decreases in the stiffness
of the whole lens. While it is possible that other mechanisms
were responsible for lens softening, the simplest explanation
is that the decrease in stiffness was a direct result of the
changes to the structure of the actomyosin lattice wrought by
the disruptors. It should be noted that a small number of lenses
treated with inhibitors in the compression trials showed an
increase in stiffness; however, this result is likely due to the
biologic variation among lenses. It is known that variations
exist in lenses; lenses of the same age will show variations in
thickness and the anterior surface shows a higher variation in
curvature than the posterior surface. Compression forces are
presumably related to the thickness and the shape of the lens;
therefore, variations in both these parameters could confer
variations in the compression response [33].

© 2015 Molecular Vision

Responses were reversible for all three disruptors, but
the kinetics of recovery differed. Latrunculin-treated lenses
recovered the slowest, perhaps due to the ubiquitous presence
of actin microfilaments, found not only at the lens capsule
and BMC, but also within the lens cortex and nucleus, the
latter two of which form the bulk of the lens [7]. More actin
would presumably require more time to reassemble. Although
optimal assembly conditions for actin and myosin differ, it
should be noted that, at least theoretically, actin has a slower
association rate than myosin II. The elongation rates of actin
filaments are 11.6±1.2×10 −6 M−1s−1 at the barbed ends and
1.3±0.2×10 −6 M−1s−1 at the pointed ends [34] compared to
myosin II, which has an immensely faster rate of ≥2.0×108
M−1s−1 [35]. It is most likely that blebbistatin and ML-7-treated
lenses were much faster in their recovery times because these
disruptors do not physically segregate the target protein into
its monomeric components. Instead, the myosin disruptors
act by preventing phosphorylation and competitively binding
to key structures in the actomyosin cascade, a process that is
presumably easier and quicker to reverse [25,36].

Figure 7. Time course of lenticular
stiff ness following disr uptor
removal. Longitudinal recovery
effects of (A) 10 µM latrunculin (n
= 6), (B) 10 µM blebbistatin (n =
6), and (C) 10 µM ML-7 (n = 6) on
lens stiffness compared to vehicle
controls. Asterisks (*) indicate
significant differences between
disr uptor- and vehicle-treated
lenses.
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It should be noted that in preliminary trials, the acute
treatment of lenses with a higher concentration of ML-7
(100 µM) resulted in lens stiffening, with 4 of 16 lenses
physically bursting during force-compression trials (data not
shown). Stiffening as a result of high concentrations of ML-7
could be due to a biphasic dose response of the MLCK inhibitor. Indeed, in the case of cell spreading, another process
mediated by the dynamics of the actomyosin network, ML-7
has opposite effects in COS7 carcinoma cells when its dose
is increased by a factor of five [37]. Moreover, results of
two-dimensional gel electrophoresis of 100 µM ML-7-treated
posterior lens capsule tissues suggest increases in protein
phosphorylation compared to samples treated with10 µM
ML-7 (data not shown).
In a related study on lens shape changes by Luck and
Choh [21], low and high concentrations of ML-7 resulted
in longer and shorter avian lens focal lengths, respectively.
Although the directionality of 10 and 100 µM changes is in
agreement with the stiffening observed in our experiment,
we did not observe any focal length changes with these two
ML-7 concentrations. One difference may be that Luck and
Choh conducted the optical trials on lenses in situ, where
the lens was still in its accommodative apparatus, while we
conducted our optical trials on lenses in vitro, i.e., on lenses
that had been extracted from their surrounding tissue. In our
experiments, lenses may have been “rounded up,” a phenomenon that has been described before for lenses separated
from their surrounding anatomy [38]. This idea seems to be
supported by the average focal length of our vehicle-treated
lenses (14.1±0.2 mm; data not shown), which was shorter and
therefore more powerful than the vehicle-treated lenses in
Luck and Choh’s study (19.6 mm). It is possible that in our
experiment, lenses were maximally rounded and therefore,
any further release of tension associated with the actinmyosin network would be too small to detect.
Indications that cytoskeletal proteins might play a role
in lenticular biomechanics were noted by Rafferty et al. [39],
who showed that increasing intracellular calcium levels in
rabbit anterior epithelial cells in the lens resulted in changes
in actin stress fiber distributions. Although the concentration of myosin is generally lower than actin in contractile
networks, such as those found in lens epithelial cells [14],
it is nonetheless crucial for structural integrity. Two of the
disruptors used targeted myosin or myosin function and both
were able to exert effects that were similar to those exerted
by the actin disruptor. However, it should also be noted that
cytoskeletal integrity is not limited to the actomyosin system;
intermediate filaments and microtubules also play a role in
maintaining the cellular architecture [8]. Lenses from mice

© 2015 Molecular Vision

in which a gene for beaded filaments, which belongs to the
intermediate filament gene family, is knocked out are less
stiff than those from wild-type mice are [17]. Our results add
to the growing body of evidence showing the importance
of cytoskeletal protein integrity to lenticular biomechanics.
While studies by Fudge et al. [17] and the present study
examined how disrupting cytoskeletal integrity affects the
biomechanics of the lens as a whole, a previous study investigated their effects on lenticular cells individually. Unlike
our results, Hozic et al. [40] showed no difference in the
stiffness of the individual lenticular cells with cytochalasin,
an actin disruptor. The difference between the present study
and that of Hozic et al. [40] may be related to the disruptor
used (latrunculin versus cytochalasin B); cytochalasin works
by inhibiting actin polymerization, essentially preventing
the formation of actin networks (blocks monomer addition),
while latrunculin depolymerizes f-actin.
In both the acute and longitudinal compression trials,
lenses were kept in TS in temperatures at or above 5 °C to
retard cell metabolism and prevent the tissue from degrading,
particularly for the longitudinal trials that required ex vivo
viability for durations greater than 32 h. It should be noted
that lenses in situ would be closer to body temperature [41];
moreover, cold temperatures could promote the depolymerization of actin microfilaments. Hall et al. [42,43] showed
that cells exposed to a temperature of 4 °C for 2–4 h exhibit
a marked thinning of actin filaments. However, Matthews
et al. [44] found no effects of these conditions on the actin
structure. Our lenses were exposed to a minimum of 5 °C for
a maximum of 15 min, and thus the cold-induced depolymerization of f-actin should have been minimal. Furthermore,
any cold-induced depolymerization was accounted for by our
control lenses, which experienced identical conditions aside
from the disruptor treatment.
The confocal imaging and western blots together indicate
that the disruptors penetrated the lens at a deep enough level
to affect the cytoskeletal distribution at the BMC in addition to the lens fiber cells. Given that confocal images were
acquired between 12 and 13 µm below the lens capsule, it
is known that the depth of the disruptor penetration is at
least to this extent. It is unclear how deeply the disruptors
penetrate the lens, as well as whether they diffuse uniformly
throughout the lens; however, it is sure to be different, as a
disparity between the diffusion patterns at the surface of the
lens compared to the lens core syncytium exists and has been
shown by Shestapolov and Bassnett [45,46].
While f-actin depolymerization was an expected
outcome of latrunculin treatment, myosin organization was
also affected (Figure 6A). It has been proposed that in order
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for myosin II to remain in the cytoskeleton, it must be bound
to stable actin [47]. Similarly, blebbistatin also appears to
enhance the depolymerization of f-actin (Figure 6C). Blebbistatin is known to disassemble actin [48], presumably by
reducing myosin activity and therefore actin cross-linkings.
Although ML-7 affects phosphorylation and therefore
the ability of actin and myosin to interact, it would not be
expected to physically alter the architecture of the actomyosin
network, which was indeed the case (ML-7-treated R n =
2.02±0.02 versus vehicle-treated R n = 2.01±0.02; data not
shown).
Our results showed that despite the cytoskeletal distribution changes at the BMC and the measured changes in
stiffness, the optics of the isolated lenses were unaffected
by the disruptors (Table 1), and during the acute study trials,
it was noted that lenses maintained transparency (note the
clarity of the lens in Figure 1). Either the disruption at the
BMC was too small to confer a change in SA and scatter, or
the regular arrangement and tight packing of the lens fiber
cells rendered any disruption of the actomyosin distributions
negligible. However, while lenses were clear during the acute
experiment, the long-term effects of disruptors on lenticular
transparency remain unknown; a qualitative assessment of
the lenses indicated that incubation with disruptors for about
1 h resulted in turbidity and the development of cataracts
(data not shown). Whether turbid lenses can recover optical
clarity also remains unknown; therefore, the use of cytoskeletal disruptors as permanent effectors for changing lens
biomechanics must take into account other possible effects on
functions such as optical clarity.
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the finding that a geodesic hexagonal network is present at the
posterior surface may simply reflect the shape of the highly
organized fiber cells and function to resist deformations that
could disrupt this organization.
In summary, we found that the disruption of actomyosin
networks in young avian lenses causes significant decreases
in the stiffness of isolated lenses, but there are no differences
in their optical properties. These results are consistent with
the hypothesis that lens stiffness may be actively tuned via
adjustments to the actomyosin networks in lens cells. The
lack of an effect on lens optical properties may have been
due to a “rounding up” artifact caused by the isolation of the
lens from the eye.
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